GlassScriptPhysician profile
William C Brunner
NPI 1639125818
$644.98
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $102.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $237.69 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $71.11 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $47.13 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $45.70 | 2019 | |
| Genentech USA, INC. | $42.43 | 2019 | |
| Dusa Pharmaceuticals, INC. | $28.13 | 2019 | |
| Sun Pharmaceutical Industries INC. | $27.93 | 2019 | |
| Celgene Corporation | $27.75 | 2019 | |
| Lilly USA, LLC | $25.69 | 2019 | |
| Janssen Biotech, INC. | $22.05 | 2019 | |
| Genzyme Corporation | $15.03 | 2019 | |
| Kyowa Kirin, INC. | $14.75 | 2020 | |
| Merck Sharp & Dohme LLC | $13.55 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $13.10 | 2019 | |
| Pfizer INC. | $12.94 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Brunner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.